Biologics: targeting systemic inflammation in psoriasis

被引:2
|
作者
Gjersvik, Petter [1 ,2 ]
机构
[1] Univ Oslo, Inst Clin Med, Oslo, Norway
[2] Oslo Univ Hosp, Dept Dermatol, NO-0270 Oslo, Norway
关键词
DISEASE;
D O I
10.1111/bjd.16775
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:247 / 248
页数:2
相关论文
共 50 条
  • [21] The Value of Indirect Comparisons of Systemic Biologics for Psoriasis: Interpretation of Efficacy Findings
    Matthias Augustin
    Christopher Schuster
    Can Mert
    Alexander Nast
    Dermatology and Therapy, 2022, 12 : 1711 - 1727
  • [22] Medication adherence among patients with psoriasis on traditional systemic and biologics treatment
    Hambly, R.
    Kelly, A.
    Gilhooley, E.
    Dhonncha, E. Nic
    Murad, A.
    Hughes, R.
    Lally, A.
    Kirby, B.
    BRITISH JOURNAL OF DERMATOLOGY, 2018, 178 (01) : E46 - E48
  • [23] Comparative effectiveness of psoriasis treatments on systemic inflammation
    Osbourne, A. S.
    McCormick, T. S.
    Cooper, K. D.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2018, 138 (05) : S100 - S100
  • [24] Adipokines, psoriasis, systemic inflammation, and endothelial dysfunction
    Lynch, Maeve
    Ahern, Tomas
    Sweeney, Cheryl M.
    Malara, Anna
    Tobin, Anne-Marie
    O'Shea, Donal
    Kirby, Brian
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2017, 56 (11) : 1103 - 1118
  • [25] Comparison of the efficacy of biologics versus conventional systemic therapies in the treatment of psoriasis at a comprehensive psoriasis care center
    Kim, Noori
    Madani, Abdulaziz
    Gottlieb, Alice
    Alkofide, Maha
    Dumont, Nicole
    Au, Shiu-Chung
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2013, 68 (04) : AB195 - AB195
  • [26] Comparison of the Efficacy of Biologics Versus Conventional Systemic Therapies in the Treatment of Psoriasis at a Comprehensive Psoriasis Care Center
    Au, Shiu-chung
    Madani, Abdulaziz
    Alhaddad, Marwan
    Alkofide, Maha
    Gottlieb, Alice B.
    JOURNAL OF DRUGS IN DERMATOLOGY, 2013, 12 (08) : 861 - 866
  • [27] IL-17–targeting biologics aim to become standard of care in psoriasis
    Mark Ratner
    Nature Biotechnology, 2015, 33 : 3 - 4
  • [28] IL-17-targeting biologics aim to become standard of care in psoriasis
    Ratner, Mark
    NATURE BIOTECHNOLOGY, 2015, 33 (01) : 3 - 4
  • [29] Differential Effects of Biologics on Psoriasis-Related Vascular Inflammation and Risk of Thrombosis
    Garcia-Martinez, Patricia
    Collado-Diaz, Victor
    Mateu-Puchades, Almudena
    Villarroel-Vicente, Carlos
    Rovira-Llopis, Susana
    Blas-Garcia, Ana
    Alvaez, Angeles
    Vicente Esplugues, Juan
    Andujar, Isabel
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2020, 140 (11) : 2294 - +
  • [30] Nail Psoriasis and Biologics
    Noiles, Kristin
    Vender, Ronald
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2009, 13 (01) : 1 - 5